Clinical trial
A Random, Open-label Multicenter, Phase IV Study Assessing the Efficacy and Safety of Two Regimens of Anti-VEGF Therapy in Chinese Patients With Polypoidal Choroidal Vasculopathy
NCT04380974 is registered in ClinicalTrials.gov with Xiaodong Sun as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Random, Open-label Multicenter, Phase IV Study Assessing the Efficacy and Safety of Two Regimens of Anti-VEGF Therapy in Chinese Patients With Polypoidal Choroidal Vasculopathy
- Lead sponsor
- Xiaodong Sun
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- June 30, 2020
- Completion date
- September 30, 2022
- Enrollment
- 102 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.